Bibliography - Disposable Bioprocessing Systems - page 263

Farid, S.S. 2009. Process economic drivers in industrial monoclonal antibody manu-
facture. In Gottschalk, U. (ed.), Process Scale Purification of Antibodies . New York:
Wiley, 239-262.
Farshid, M., Taffs, R.E., Scott, D., Asher, D.M., and Brorson, K. 2005. The clearance of
viruses and transmissible spongiform encephalopathy agents from biologicals.
Curr. Opin. Biotechnol . 16: 561-567.
FDA. 1987. Guideline on Sterile Drug Products Produced by Aseptic Processing.
Rockville, MD: FDA.
FDA. 2004. Equipment cleaning and maintenance. Code of Federal Regulations (CFR)
Part 211.67 Title 21 Rev. FDA, Rockville, MD, May 25.
Fenge, C. and Lüllau, E. 2006. Cell culture bioreactors. In Ozturk, S.S. and Hu, W.S.
(eds.), Cell Culture Technology for Pharmaceutical and Cell-Based Therapies . New
York: CRC Press, 155-224.
Fermentation—History—Ferments, Living, Cell, Debate, Result, and Cells http://
science.jrank.org/pages/2675/Fermentation-History.html#ixzz1IeED0utS .
Fichtner, S., Giese, U., Phal, I., and Reif, O.W. 2006. Determination of “extractables”
on polymer materials by means of HPLC-MS. PDA J. Pharm. Sci. Technol . 60:
291-301.
Forster, R. and Ishikawa, M. 1999. The methodologies for impact assessment of plastic
waste management options—How to handle economic and ecological impacts?
Proceedings R99. Geneva.
Foulon, A. et al. 2008. Using disposables in an antibody production process. BioProcess
Int . 6(6): 12-18.
Foulon, A., Trach, F., Pralong, A., Proctor, M., and Lim, J. 2008. Using disposables in
an antibody production process: A cost-effectiveness study of technology trans-
fer between two production sites. BioProcess Int. 6 (Suppl 3): 12-18.
Fox, S. 2005. Disposable processing: The impact of disposable bioreactors on the CMO
industry. Contract Pharma. 6: 62-74.
Fraud, N., Kuczewski, M., Zarbis-Papastoitsis, G., and Hirai, M. 2009. Hydrophobic
membrane adsorbers for large-scale downstream processing. BioPharm. Int . 23:
24-27.
Fries, S., Glazomitsky, K., Woods, A., Forrest, G., Hsu, A., Olewinski, R., Robinson,
D., and Chartrain, M. 2005. Evaluation of disposable bioreactors. BioProcess Int .
3(Suppl 6): 36-44.
Fuller, M. and Pora, H. 2008. Introducing disposable systems into biomanufacturing:
A CMO case study. BioProcess Int . 6(10): 30-36.
Galliher, P. 2008. Achieving high-efficiency production with microbial technology in
a single-use bioreactor platform. BioProcess Int. 11: 60-65.
Ganzlin, M., Marose, S., Lu, X., Hitzmann, B., Scheper, T., and Rinas, U. 2007. In situ
multi-wavelength fluorescence spectroscopy as effective tool to simultaneously
monitor spore germination, metabolic activity and quantitative protein produc-
tion in recombinant Aspergillus niger fed-batch cultures. J. Biotechnol . 132 (4):
461-468.
GE Healthcare. 2006. CHO cell supernatant concentration with Kvick Lab cassettes.
Application note 11-0013-62.
GE Healthcare. 2007. Purification of a monoclonal antibody using ReadyToProcess
columns. Application Note 28-9198-56 AA.